CDH1 and neoplasm: This corroborates well with previous studies that showed differences in the expression and prognostic value of various other potential biomarkers such as proliferation marker Ki67, p63, E‐cadherin, RPS6 or when evaluated at ITF and tumour centre (tumour propria) 25, 26, 27, 28.